Christopher J. Ormandy

10.6k total citations · 1 hit paper
110 papers, 7.2k citations indexed

About

Christopher J. Ormandy is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Christopher J. Ormandy has authored 110 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 44 papers in Oncology and 35 papers in Genetics. Recurrent topics in Christopher J. Ormandy's work include Growth Hormone and Insulin-like Growth Factors (30 papers), Estrogen and related hormone effects (20 papers) and Cancer Cells and Metastasis (17 papers). Christopher J. Ormandy is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (30 papers), Estrogen and related hormone effects (20 papers) and Cancer Cells and Metastasis (17 papers). Christopher J. Ormandy collaborates with scholars based in Australia, United States and France. Christopher J. Ormandy's co-authors include Nadine Binart, Paul A. Kelly, Samantha R. Oakes, Robert L. Sutherland, Matthew J. Naylor, B. K. Lucas, Heather Lee, Elizabeth A. Musgrove, Jessica Harris and Diane Damotte and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Christopher J. Ormandy

110 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse.

1997 643 citations Christopher J. Ormandy, B. K. Lucas et al. Genes & Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Ormandy Australia	51	3.5k	2.6k	1.9k	1.6k	1.0k	110	7.2k
Vincent Goffin France	49	3.0k 0.9×	1.7k 0.7×	1.9k 1.0×	3.9k 2.5×	805 0.8×	167	8.5k
Jolene J. Windle United States	43	4.5k 1.3×	2.5k 1.0×	1.1k 0.6×	570 0.4×	778 0.7×	137	7.7k
Jacques Samarut France	58	5.3k 1.5×	1.0k 0.4×	2.4k 1.3×	2.9k 1.9×	777 0.7×	180	9.5k
Edward J. Filardo United States	35	3.1k 0.9×	1.2k 0.5×	5.0k 2.6×	1.6k 1.0×	506 0.5×	46	7.5k
Kay‐Uwe Wagner United States	55	5.5k 1.6×	5.1k 2.0×	1.9k 1.0×	734 0.5×	1.8k 1.7×	161	10.8k
Jean Djiane France	49	3.3k 0.9×	1.4k 0.6×	2.5k 1.3×	3.8k 2.4×	643 0.6×	231	9.1k
Debabrata Chakravarti United States	39	5.8k 1.6×	1.2k 0.5×	2.2k 1.1×	373 0.2×	1.0k 1.0×	77	8.5k
Manuel Mark France	33	7.6k 2.2×	1.1k 0.4×	5.5k 2.8×	1.4k 0.9×	756 0.7×	49	11.8k
Enzo Lalli France	45	4.1k 1.1×	402 0.2×	2.8k 1.4×	1.7k 1.1×	1.1k 1.1×	131	7.0k
Björn Vennström Sweden	61	5.6k 1.6×	1.2k 0.5×	3.6k 1.9×	4.5k 2.9×	471 0.4×	136	11.1k

Countries citing papers authored by Christopher J. Ormandy

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Ormandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Ormandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Ormandy more than expected).

Fields of papers citing papers by Christopher J. Ormandy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Ormandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Ormandy. The network helps show where Christopher J. Ormandy may publish in the future.

Co-authorship network of co-authors of Christopher J. Ormandy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Ormandy. A scholar is included among the top collaborators of Christopher J. Ormandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Ormandy. Christopher J. Ormandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zammit, Nathan W., Joanna Warren, Yan‐Chuan Shi, et al.. (2022). TNFAIP3 Reduction-of-Function Drives Female Infertility and CNS Inflammation. Frontiers in Immunology. 13. 811525–811525. 7 indexed citations

Piggin, Catherine, Daniel Roden, Andrew M. K. Law, et al.. (2020). ELF5 modulates the estrogen receptor cistrome in breast cancer. PLoS Genetics. 16(1). e1008531–e1008531. 16 indexed citations

Valdés‐Mora, Fátima, Kristina Handler, Andrew M. K. Law, et al.. (2018). Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology. Frontiers in Immunology. 9. 2582–2582. 43 indexed citations

Young, Adelaide I.J., Paul Timpson, David Gallego‐Ortega, Christopher J. Ormandy, & Samantha R. Oakes. (2017). Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion. Cell Adhesion & Migration. 12(6). 513–523. 25 indexed citations

Piggin, Catherine, Daniel Roden, David Gallego‐Ortega, et al.. (2016). ELF5 isoform expression is tissue-specific and significantly altered in cancer. Breast Cancer Research. 18(1). 4–4. 35 indexed citations

Owens, Thomas W., Sarah A. Best, Alison Ferguson, et al.. (2014). Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer. Cancer Research. 74(18). 5277–5286. 60 indexed citations

Stone, Andrew, Mark J. Cowley, Fátima Valdés‐Mora, et al.. (2013). BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer. Molecular Cancer Therapeutics. 12(9). 1874–1885. 39 indexed citations

Jamsai, Duangporn, Brett Clark, Stephanie J. Smith, et al.. (2013). A Missense Mutation in the Transcription Factor ETV5 Leads to Sterility, Increased Embryonic and Perinatal Death, Postnatal Growth Restriction, Renal Asymmetry and Polydactyly in the Mouse. PLoS ONE. 8(10). e77311–e77311. 13 indexed citations

Zardawi, Ibrahim M., Catriona M. McNeil, Ewan K.A. Millar, et al.. (2010). High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype. Histopathology. 56(3). 286–296. 48 indexed citations

10.

Alles, M. Chehani, Margaret Gardiner‐Garden, David J. Nott, et al.. (2009). Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup. PLoS ONE. 4(3). e4710–e4710. 79 indexed citations

11.

Oakes, Samantha R., Matthew J. Naylor, Marie-Liesse Asselin-Labat, et al.. (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes & Development. 22(5). 581–586. 186 indexed citations

12.

Oakes, Samantha R., et al.. (2008). Prolactin Regulation of Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia. 13(1). 13–28. 115 indexed citations

13.

Hilton, Heidi N., Prudence M. Stanford, Jessica Harris, et al.. (2007). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(3). 383–393. 40 indexed citations

14.

Oakes, Samantha R., et al.. (2006). Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene. 26(4). 543–553. 64 indexed citations

15.

Binart, Nadine, Christopher J. Ormandy, & Paul A. Kelly. (2005). Mammary Gland Development and the Prolactin Receptor. Kluwer Academic Publishers eBooks. 480. 85–92. 16 indexed citations

16.

Kindblom, Jon, Karin Dillner, Lena Sahlin, et al.. (2003). Prostate Hyperplasia in a Transgenic Mouse with Prostate-Specific Expression of Prolactin. Endocrinology. 144(6). 2269–2278. 92 indexed citations

17.

Goffin, Vincent, Nadine Binart, Philippe Clément-Lacroix, et al.. (1999). From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genetic Analysis Biomolecular Engineering. 15(3-5). 189–201. 59 indexed citations

18.

Ormandy, Christopher J., et al.. (1998). Amplification, expression, and steroid regulation of the preprogalanin gene in human breast cancer.. PubMed. 58(7). 1353–7. 17 indexed citations

19.

Ormandy, Christopher J.. (1997). Coexpression and Cross-Regulation of the Prolactin Receptor and Sex Steroid Hormone Receptors in Breast Cancer. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3692–3699. 78 indexed citations

20.

Ormandy, Christopher J.. (1992). Transcriptional regulation of prolactin receptor gene expression by sodium butyrate in MCF-7 human breast cancer cells. Endocrinology. 131(2). 982–984. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact